-
Sector Analysis
NewAntibody-Drug Conjugates (ADC) Overview, Industry Trends, Marketed and Pipeline Products, Opportunities and Challenges
Antibody-Drug Conjugates Market Report Overview An Antibody-Drug Conjugates (ADC) drug consists of monoclonal antibodies conjugated to a payload via a linker, for the precise targeting of antigen-positive cancer cells. ADCs are developed to target protein receptors with high expression such as HER2, TROP-2, CD22, and others. There are two cytotoxic payload types predominantly used in ADCs including microtubule inhibitors, and the more potent DNA-damaging payloads such as topoisomerase I inhibitors. The ADC market research report will aid clients in gaining...
-
Sector Analysis
NewCell and Gene Therapies in Ophthalmology – Disease Overview, Treatment Options and Future Market Assessment
Cell and Gene Therapies in Ophthalmology Market Report Overview The Cell and Gene Therapies (CGT) in ophthalmology market was $46 million in 2023. The market will experience moderate growth during the forecast period with gene therapies targeting Leber congenital amaurosis (LCA) and retinitis likely to be the primary drivers of the CGT market in the ophthalmology space. The CGT in ophthalmology market research report will aid clients in gaining insight into the competitive landscape of leading CGT agents in ophthalmology...
-
Innovation Ranking
NewInnovation Ranking – F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases. It provides medicines for the treatment of cancer, other auto-immune diseases, central nervous system disorders, ophthalmological disorders, infectious diseases, and respiratory diseases. The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. Roche conducts research to identify novel methods to prevent, diagnose, and treat diseases. The company offers its products and services to hospitals, healthcare professionals, commercial laboratories,...
-
Product Insights
NewGraft Versus Host Disease (GVHD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Graft Versus Host Disease (GVHD) Clinical Trial Market Report Overview Graft versus host disease (GVHD) clinical trial market research report provides top line data relating to the clinical trials on Graft Versus Host Disease (GVHD). The report includes an overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent...
-
Product Insights
NewObsessive-Compulsive Disorder Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Obsessive-Compulsive Disorder Clinical Trial Market Report Overview Obsessive-compulsive disorder clinical trial market research report provides top line data relating to the clinical trials on obsessive-compulsive disorder. The report includes an overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials. Key...
-
Sector Analysis
NewReproductive Hormones and Proteins Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Reproductive Hormones and Proteins Tests Market Report Overview The reproductive hormones and proteins tests market size was $119.1 million in 2023. The market is expected to grow at a CAGR of more than 1% during 2023-2033. Reproductive hormones and proteins assist in the control and regulation of physiological processes including metabolism, reproduction, and growth and development. They are secreted either from endocrine glands or from organs with secondary endocrine functions and affect the health and behavior of both males and...
-
Sector Analysis
NewImmunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Immunochemistry Analyzers Market Report Overview The immunochemistry analyzers market size was valued at $1.41 billion in 2023 and is expected to grow at a CAGR of more than 4% during 2023-2033. Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins, and therapeutic drugs. They are typically offered in modular increments, which can operate independently or simultaneously as a unit. Immunochemistry Analyzers Market Outlook, 2023-2033 ($ Billion) Buy the Full Report for More Insights into...
-
Sector Analysis
NewPolymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on PCR Systems market for the year 2020 and beyond. Polymerase Chain Reaction (PCR) Systems are used for diagnosis and screening of a wide array of infectious disease as well as for testing of cancer patients and hereditary diseases. Nucleic...
-
Sector Analysis
NewPoint of Care (POC) Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Point of Care (POC) Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Point of Care (POC) Analyzers market for the year 2020 and beyond. The need for rapidity of results for immediate and effective clinical intervention, and recent technological advances and the fact that it is not always feasible for physicians...